UBS Group »

Telomir Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Telomir Pharmaceuticals

Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 202520k40k60k80k100k5k10k15k20k25k
Value ($)Share countHistorical TELO position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $103k 25k 4.12
2024-09-30 $24k 3.8k 6.42
2024-06-30 $29k 5.9k 4.81

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Telomir Pharmaceuticals

Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Goldman Sachs Group
Charles Schwab Investment Management
Jpmorgan Chase & Co
Morgan Stanley
Barclays
Transce3nd
Nuveen Asset Management
UBS Group

View all funds holding Telomir Pharmaceuticals